Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting ; volume:8 ; number:1 ; day:04 ; month:7 ; year:2008 ; pages:1-8 ; date:12.2008
BMC infectious diseases ; 8, Heft 1 (04.7.2008), 1-8, 12.2008
- Urheber
-
Badri, Motasim
- Beteiligte Personen und Organisationen
-
Lawn, Stephen D.
Wood, Robin
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-8-89
- URN
-
urn:nbn:de:1111-2016030252617
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Badri, Motasim
- Lawn, Stephen D.
- Wood, Robin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Novel MDR-reversing inhibitors of MRP subtypes related to antiretroviral drug resistance and CD4 cell counts
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
Estimating health workforce needs for antiretroviral therapy in resource-limited settings
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Novel MDR-reversing inhibitors of MRP subtypes related to antiretroviral drug resistance and CD4 cell counts
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
Estimating health workforce needs for antiretroviral therapy in resource-limited settings
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Differences in CD4 count increases in veterans starting antiretroviral therapy with lopinavir/ritonavir or efavirenz
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Novel MDR-reversing inhibitors of MRP subtypes related to antiretroviral drug resistance and CD4 cell counts
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome